MCM
OREX

Munder Capital Management’s Orexigen Therapeutics, Inc. OREX Stock Holding History

Munder Capital Management’s Portfolio OREX Stock Details OREX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		$382K Sell
8,956
-763
-8% -$41K ﹤0.01% 523
2014
Q2 		$601K Sell
9,719
-342
-3% -$19.9K ﹤0.01% 491
2014
Q1 		$654K Buy
+10,061
New +$680K ﹤0.01% 487

Other funds holding OREX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Munder Capital Management's OREX Position: Q3 2014 in Review

Munder Capital Management reduced its Orexigen Therapeutics, Inc. (OREX) stake by 7.9% in Q3 2014, selling an estimated $41K and leaving 8,956 shares worth $382K. The position accounts for ﹤0.01% of the portfolio, ranked #523.

Munder Capital Management first reported a position in OREX in Q1 2014 and has held it in 3 quarters since. The position peaked at $654K in Q1 2014. 128 funds tracked by Wall St. Rank hold OREX as of Q3 2014.

  • Munder Capital Management held 8,956 shares of Orexigen Therapeutics, Inc. worth $382K as of Q3 2014.
  • Munder Capital Management sold 763 Orexigen Therapeutics, Inc. shares in Q3 2014, an estimated $41K.
  • Orexigen Therapeutics, Inc. made up ﹤0.01% of Munder Capital Management's portfolio in Q3 2014, its #523 holding.
  • Munder Capital Management first reported a position in Orexigen Therapeutics, Inc. in Q1 2014 and has held it in 3 quarters since.
  • Munder Capital Management's Orexigen Therapeutics, Inc. position peaked at $654K in Q1 2014.
  • 128 funds tracked by Wall St. Rank held Orexigen Therapeutics, Inc. as of Q3 2014.

Based on Munder Capital Management's 13F filing for Q3 2014, filed 31 Oct 2014.